February 28, 2015 1:10 PM ET


Company Overview of Cambridge Major Laboratories, Inc.

Company Overview

Cambridge Major Laboratories, Inc. develops and manufactures active pharmaceutical ingredients. The company offers a range of outsourcing services from early preclinical stages to post-NDA commercial manufacture to pharmaceutical and biotechnology industries. Its services include solid state chemistry, formulation development, analytical development and testing, clinical and commercial finished dosage form manufacturing (solid dose and parenteral), packaging, and stability. Cambridge Major Laboratories, Inc. was formerly known as Cambridge Chemical Inc. and changed its name to Cambridge Major Laboratories, Inc. in 1999. The company is based in Germantown, Wisconsin with facilities in Europe ...

W130 N10497 Washington Drive

Germantown, WI 53022

United States





Key Executives for Cambridge Major Laboratories, Inc.

Chief Executive Officer
Age: 49
Founder, Non-Executive Chairman and Scientific Advisor
Chief Financial Officer and Executive Vice President
Age: 57
President of Cml Europe
Chief Information Officer and Vice President of Information Technology
Compensation as of Fiscal Year 2014.

Cambridge Major Laboratories, Inc. Key Developments

Cambridge Major Laboratories Inc. Announces More Than $20 Million Expansion of its Germantown Facility

Cambridge Major Laboratories Inc. has received an incentive package from state and local governments worth as much as $2 million as part of a more than $20 million expansion of its Germantown facility. The expansion is expected to create more than 75 jobs during the next three years. Cambridge Major's expansion will include a new administrative headquarters, as well as additions to its research and development and manufacturing capacity. The expansion is scheduled to be completed by the end of 2015.

Cambridge Major Laboratories Appoints Marcel Schreuder Goedheijt as General Manager, Cambridge Major Laboratories, Inc.'s Europe

AAIPharma Services Corp. and Cambridge Major Laboratories, Inc. announced the appointment of Marcel Schreuder Goedheijt, Ph.D. as General Manager, Cambridge Major Laboratories, Europe. In this role, Marcel is responsible for directing the day to day business activities as a leading global service-based chemistry outsourcing partner to the pharmaceutical and biotechnology industries - producing pharmaceutical intermediates, API's and other fine organic chemicals. With over 15 years of experience in the chemical and pharmaceutical industries, Dr. Schreuder Goedheijt has held leadership positions at DSM Pharma Chemicals, MSD (Organon) and Diosynth.

AAIPharma Services Corp. and Cambridge Major Laboratories, Inc. Appoint Stephan Kutzer as Chief Executive Officer, Effective August 1, 2014

AAIPharma Services Corp. and Cambridge Major Laboratories, Inc. announced the appointment of Stephan Kutzer, Ph.D. as Chief Executive Officer (CEO), effective August 1, 2014. Most recently, Dr. Kutzer served as Chief Operating Officer of Lonza Inc. Since 2003, he has also served as Chief Operating Officer and/or President of several divisions, including Lonza Pharma Biotech Division, Lonza Custom Manufacturing, Lonza Biopharmaceuticals and Lonza Performance Chemicals.

Similar Private Companies By Industry

Company Name Region
Mylan LLC United States
Gyma Laboratories of America, Inc. United States
Honeywood, LLC United States
Sanford Applied Biosciences, LLC United States
FSC Laboratories, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Cambridge Major Laboratories, Inc., please visit www.c-mlabs.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.